Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

596 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The future of chronic obstructive pulmonary disease treatment--difficulties of and barriers to drug development.
Martinez FJ, Donohue JF, Rennard SI. Martinez FJ, et al. Among authors: rennard si. Lancet. 2011 Sep 10;378(9795):1027-37. doi: 10.1016/S0140-6736(11)61047-7. Lancet. 2011. PMID: 21907866 Review.
Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R. Levin DC, et al. Among authors: rennard si. Am J Med. 1996 Jan 29;100(1A):40S-48S. doi: 10.1016/s0002-9343(96)80073-8. Am J Med. 1996. PMID: 8610716 Clinical Trial.
New therapeutic drugs in the management of chronic obstructive pulmonary disease.
Rennard SI. Rennard SI. Curr Opin Pulm Med. 2002 Mar;8(2):106-11. doi: 10.1097/00063198-200203000-00005. Curr Opin Pulm Med. 2002. PMID: 11845005 Review.
COPD in 2001: a major challenge for medicine, the pharmaceutical industry, and society.
Rennard SI, Farmer SG. Rennard SI, et al. Chest. 2002 May;121(5 Suppl):113S-115S. doi: 10.1378/chest.121.5_suppl.113s. Chest. 2002. PMID: 12010837 No abstract available.
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey.
Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, Vestbo J. Rennard S, et al. Eur Respir J. 2002 Oct;20(4):799-805. doi: 10.1183/09031936.02.03242002. Eur Respir J. 2002. PMID: 12412667
COPD: treatments benefit patients.
Rennard SI. Rennard SI. Lancet. 2003 Feb 8;361(9356):444-5. doi: 10.1016/S0140-6736(03)12467-1. Lancet. 2003. PMID: 12583937 No abstract available.
Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.
Gamble E, Grootendorst DC, Brightling CE, Troy S, Qiu Y, Zhu J, Parker D, Matin D, Majumdar S, Vignola AM, Kroegel C, Morell F, Hansel TT, Rennard SI, Compton C, Amit O, Tat T, Edelson J, Pavord ID, Rabe KF, Barnes NC, Jeffery PK. Gamble E, et al. Among authors: rennard si. Am J Respir Crit Care Med. 2003 Oct 15;168(8):976-82. doi: 10.1164/rccm.200212-1490OC. Epub 2003 Jun 19. Am J Respir Crit Care Med. 2003. PMID: 12816740 Clinical Trial.
Treatment of stable chronic obstructive pulmonary disease.
Rennard SI. Rennard SI. Lancet. 2004 Aug 28-Sep 3;364(9436):791-802. doi: 10.1016/S0140-6736(04)16941-9. Lancet. 2004. PMID: 15337408 Review.
Pathogenesis of COPD.
Spurzem JR, Rennard SI. Spurzem JR, et al. Among authors: rennard si. Semin Respir Crit Care Med. 2005 Apr;26(2):142-53. doi: 10.1055/s-2005-869535. Semin Respir Crit Care Med. 2005. PMID: 16088433 Review.
Exacerbations and progression of disease in asthma and chronic obstructive pulmonary disease.
Rennard SI, Farmer SG. Rennard SI, et al. Proc Am Thorac Soc. 2004;1(2):88-92. doi: 10.1513/pats.2306026. Proc Am Thorac Soc. 2004. PMID: 16113418 Review.
596 results
Jump to page
Feedback